VACCINEXPAR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.83 USD | -1.70% |
|
+19.96% | -37.36% |
| 04-12 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
| 04-02 | Vaccinex, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar VACCINEXPAR
1ba6c207b9fe0a0.Dn3uQavBMkHs0y3i6F_4pjp0Jf0bGrqkBcVFEOFLbTA.ZQihD_P0dRK5tk-4oR2ZyU0_fYdfQtOXU6cBItYIAQhJHtcgmPV8G4-MHQ~364a634efcbbae0f61f53c89f687688a
Upcoming events on VACCINEXPAR
No events available
Past events on VACCINEXPAR
| 13/11/2023 13:00 | Q3 2023 Earnings Release |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting |
| 03/11/2023 13:00 | Society for Immunotherapy of Cancer Meeting |
| 23/10/2023 | Clinical Trials on Alzheimer Disease conference |
| 30/09/2023 | Keystone Symposium |
| 29/09/2023 21:40 | AACR Special Conference in Cancer Research: Pancreatic Cancer |
| 28/09/2023 13:35 | CHI Discovery on Target conference |
| 26/09/2023 | AACR Special Conference in Cancer Research: Pancreatic Cancer |
| 08/09/2023 13:30 | Extraordinary Shareholders Meeting |
| 14/08/2023 13:10 | Q2 2023 Earnings Release |
| 09/06/2023 15:00 | Jefferies Global Healthcare Conference |
| 04/06/2023 | BIO International Convention |
| 01/06/2023 | American Society of Clinical Oncology Conference |
| 15/05/2023 21:45 | Q1 2023 Earnings Release |
| 14/05/2023 | PEGS Boston Summit |
| 10/05/2023 | Annual General Meeting |
| 03/04/2023 13:00 | Q4 2022 Earnings Release |
| 24/03/2023 18:00 | AAIC Advancements Immunity Conference |
| 14/11/2022 13:30 | Q3 2022 Earnings Release |
| 11/11/2022 22:20 | Society for Immunotherapy of Cancer Meeting - Abstract No - 613 |
Annual results
| Fiscal Period | December | 2019 | 2020 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,52 0,57 -7.6% | 0,63 0,62 1.63% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -32,0 -34,5 7.16% | -28,3 -31,4 9.69% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,9 -34,4 7.28% | -28,9 -31,5 8.27% |
|
Net income Million USD | Released Forecast Spread | -31,9 -34,4 7.28% | -28,9 -31,5 8.27% |
|
EPS USD | Released Forecast Spread | -519 -558 6.97% | -323 -341 5.23% |
| Announcement Date | 09/03/20 | 31/03/21 |
Past sector events for VACCINEXPAR
- Stock Market
- Equities
- VCNX Stock
- Calendar VACCINEXPAR
